Free subscription to the Capitol Journal keeps you current on legislative and regulatory news.
CO Lawmakers Tweak Last Year’s First-In-Nation AI Law In a special session that began last week, Colorado Senate Majority Leader Robert Rodriguez (D) introduced legislation ( SB 4 a ) that would...
States Seek Ways to Replace Expiring Federal Health Subsidies Policymakers in California, Colorado, Maryland and other states are considering ways to backfill pandemic-era federal health insurance subsidies...
The price of electricity has risen faster than inflation since 2022, and the U.S. Energy Information Administration (EIA) expects that trend to continue through 2026 . In the past year, the cost of electricity...
Trump’s ‘Debanking’ Order Raises Questions for Lenders Days after accusing JPMorgan Chase and Bank of America of discriminating against him and other conservatives, President Donald...
Tech Groups Battling AI Regulation in CA Tech industry groups including the Business Software Alliance, the Consumer Technology Association and the Chamber of Progress are stepping up their lobbying...
* The views expressed in externally authored materials linked or published on this site do not necessarily reflect the views of LexisNexis Legal & Professional.
Alabama Gov. Kay Ivey (R) signed a bill (SB 72)—passed unanimously by both legislative chambers—that bars the state’s Board of Medical Examiners and Medical Licensure Commission from taking adverse action against doctors for prescribing or recommending off-label medical treatments. The measure’s sponsor, Sen. Arthur Orr (R) said it “just allowed a doctor to do what they’re already doing without any fear of reprisal from the State Medical Board,” adding that there are often FDA-approved drugs that can help treat ailments they weren’t initially intended to treat. (ALABAMA REFLECTOR, LEXISNEXIS STATE NET)
Inequities in the delivery of mental health care will cost the country $478 billion in 2024 and could increase to $1.3 trillion by 2040 if unchecked, according to a report from Deloitte. The report, compiled by Deloitte’s Health Equity Institute and the School of Global Health at Meharry Medical College, attributed most of those “avoidable and unnecessary expenses” to premature death and productivity loss that disproportionately impact certain populations. The analysis looked at differences in mental health outcomes among demographics segmented by race and ethnicity, socioeconomic status and age. (FIERCE HEALTH)
—Compiled by SNCJ Managing Editor KOREY CLARK
Visit our webpage to connect with a LexisNexis® State Net® representative and learn how the State Net legislative and regulatory tracking service can help you identify, track, analyze and report on relevant legislative and regulatory developments.